BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Evaluation of Azacitidine in Patients With Transplant‑ineligible Myelodysplastic Syndromes and Acute Myeloid Leukemia With Myelodysplasia‑related Changes in a Japanese Clinical Setting

Oncology Letters
Cancer ResearchOncology
2019English

A Comprehensive Overview of the Role of Azacitidine in the Management of Myelodysplastic Syndromes and Acute Myeloid Leukaemia

European Oncology and Haematology
OncologyHematology
2014English

Efficacy of Azacitidine in De Novo and Relapsed Acute Myeloid Leukemia: A Retrospective Comparative Study

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Coffee and Green Tea Consumption and Subsequent Risk of Acute Myeloid Leukemia and Myelodysplastic Syndromes in Japan

International Journal of Cancer
Cancer ResearchOncology
2017English

A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines

PLoS ONE
Multidisciplinary
2010English

Tyrosine Kinase Inhibition in Acute Myeloid Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

Myelodysplastic Syndrome/Acute Myeloid Leukemia Evolving From Aplastic Anemia: Efficacy of Hematopoietic Stem Cell Transplantation

Cellular Therapy and Transplantation
TransplantationMolecular Medicine
2018English

Mixed T Lymphocyte Chimerism After Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy